Clinproxy is a CRO with a focus on the Investigator with aspects essential for validating a drug’s remedial benefits.

Clinproxy, www.clinproxy.com is a CRO (Contract Research Organizations), who specializes in evaluating the burden of the trial and eliminating surplus protocols by focusing the Investigator on aspects critical for validating the drug’s remedial benefits. Efficiency is all about resource allocation, time-management and proper monitoring practices. Proper monitoring practices can result in the greatest outcome on the progress of a clinical trial. In any clinical situation, the well being of the public must always be weighed against the financial interests of the sponsors and their investors. A sponsor's loyalty is to their investors, but their ethical accountability is to ensure that the drugs they develop are in the best interests of the public. As a result, there is a growing need to measure potential ethical probabilities that will ultimately arise from these dynamic relationships.